Skip to main content
Caplight Logo









Aer Therapeutics

Aer Therapeutics

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://aertherapeutics.com/

Last Round

Seed Round

Aug 19, 2026

Total Funding Raised

$36M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Aer Therapeutics is a biotechnology company that develops inhaled mucolytic therapies for the treatment of muco-obstructive lung diseases such as COPD and asthma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologymucolyticrespiratory diseaseclinical trialsdrug developmentlung diseasebiotechclinical-stage biotechmucus hypersecretioninhaled therapysmall-molecule drugpulmonologydrug pipelinebiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aer Therapeutics Comparables

Compare Aer Therapeutics with similar companies based on industry and business-model similarity.

Aer Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renovion, Inc.
85%
AlgiPharma AS
82%
MucoLife Therapeutics
79%

Aer Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 19, 2026
Series AApr 13, 2023

Aer Therapeutics Investors

Notable investors and investment history

Aer Therapeutics investors
InvestorRounds
NIH RADxSeries A
Hatteras Venture PartnersSeries A
OrbiMedSeries A
Canaan PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2026

    Raised $3M in a Seed Round.

  • Jul 27, 2026

    Monthly visitors increased 145% MoM.

Aer Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aer Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aer Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range10
Year Founded2022
Last FundingAug 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?